Lead a team of 20 revenue analysts, spanning the Latham network, in Los Angeles, Hong Kong, London, Manchester, and New York.Our Revenue Analysts provide insight into the economic performance and financial health of clients, matters, and legal teams. We leverage this insight to drive strategic decisions by collaborating directly with the firm's most senior leaders, the firm's partners and associates, and our peers in Business Development, Attorney Development, Pro Bono, Knowledge Management, and Strategic Library Services. Our core work improves client retention, accelerates inventory turnover, optimizes attorney staffing, reduces fee write-offs, evaluates the strengths and opportunities of our legal practices, assesses the strategic value of current clients, and estimates the potential value of new offices and acquisitions.Launched the Firm’s Quant Team, a team of four analysts that support our Emerging Company, Capital Markets, and M&A practices, by developing client-facing financial models used in M&A transactions, SPAC, deSPAC, IPO, and early-stage/venture capital financing engagements. The team is embedded in the deal, working closely with associates, partners, and clients to ensure the model reflects the terms of the deal. The work is highly dynamic as we support the transaction up to the close. After two years, transitioned this team to a colleague.We hail from a wide range of industries: investment banking and financial services, economic and litigation consulting, biotech, aerospace r&d, digital marketing, working capital and project management consulting, supply chain management, and corporate finance.Leadership philosophy: recruit smart, driven analysts interested in learning from a team, provide training and direction, then ask them to make the team and our work better; maximize innovation and collaboration by fostering an environment of trust through honest and continuous conversation; lead by example.

Provided strategic financial support to the managing partners of the Environmental, Tax, and Litigation departmentsProvided strategic support to the CFO and the firm leadershipAdvanced the firm's project management capabilities by improving pricing analytics, matter monitoring, inventory management, and matter close out proceduresEnabled new client acquisition by working with lead partners to formulate rates, budgets and, where appropriate, alternative fee arrangementsAdministered partners' firm-provided retirement planForecasted firm revenue and unit value

Led four accountants to ensure financial statements accurately reflect all cost- and profit-sharing collaborations with third parties. Partnered with Business Development, Law, FP&A and external business partners to track spend, issue invoices, credit budgets and explain variances.

Participated in Amgen's three-year finance and strategy rotational program.3rd Year: Sales and Marketing FP&A for US Bone HealthFinancial representative for the S&M team, providing financial and strategic insight to the business by: analyzing key product and market metrics to identify demand trends and barriers to sale; developing budgets; forecasting sales; and explaining variances.2nd Year: Results Delivery OfficeFinancial representative on cross-functional executive restructuring team charged with planning and implementing strategy to consolidate global research facilities and reduce headquarter footprint.- Coordinated the development and tracking of a large cross-functional expense budget that disrupted pre-existing priorities. Designed data input templates, coordinated refresh timelines, and synthesized and presented consolidated dashboards to senior leadership during weekly meetings. - Proposed, developed and presented first-ever analysis of current and future seat demand by site and function, allowing senior leadership both to improve operating margin and, for the first time, to communicate functional headcount targets by site.- Led the analysis and valuation of several alternative implementation plans, significantly reducing steady-state operating expenses.1st Year: TaxAssisted the Transfer Pricing, Provision and Audit teams by: - Estimating the impact of House and Senate tax reform proposals on Amgen’s cash and book tax rates and presented strategic options to VP of Tax. - Managing network of intercompany agreements, incorporating new acquisitions and reflecting international expansion. - Monitoring competitor’s tax structures and reported meaningful changes to VP of Tax. - Assisting in the preparation for and responses to IRS audits.

- Developed tactics to mitigate operational and strategic risks of sourcing early stage R&D activities in India and China. - Forecasted risk-adjusted global sales from cardiovascular drug in clinical trials.

Performed economic analysis of cross-border transactions that confirmed or enabled client compliance with applicable IRS regulations